GLP-1 receptor agonists × body weight & composition

TrialJAMA2022

Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial.

Domenica M Rubino et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedrandomised · 338 people · 2022

Randomised comparison

Probably lowered body weight & composition

−9.40percentage points−12.0 to −6.80

As reported

difference −9.4 percentage points, 95% CI −12.0 to −6.80

One number in the abstract

the abstract, start to end

vs -6.4% with liraglutide (difference, -9.4 percentage points [95% CI,

← favours treatmentfavours comparator →
could be chance
Body weight & composition
−9.4−12.0 to −6.80
GLP-1 receptor agonistsBody weight & composition

GLP-1 receptor agonists × body weight & compositionhelps?replicated

unlikelylikely
0.900.90 without it
← favours treatmentfavours comparator →
this papermore certainless certain
1 / 5

456 papers cite itlatest 60 shown

2022
2025
2026
this paperpooled ittrialcites it

3 trials

Full record →Abstract, authors, funding and every citing paper · PMID 35015037